COMPOSITESWORLD, publisher of High-Performance Composites and Composites Technology magazines, has announced that the final agenda is set for Carbon Fiber 2007, which will be held Dec. 5-7, 2007, in Washington DC.
Supratek Pharma Inc. announced today that under the Special Protocol Assessment process, it has obtained agreement with the United States Food and Drug Administration for the design of its pivotal study protocol for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract.
Axiom Capital Management and Scott Livingston today announced that the Third Annual Axiom Capital Management 'Livingston Nanotechnology Conference' will feature an afternoon keynote presentation by Henry Kelly, President of the Federation of American Scientists.
Medtech Insight has announced that almost 30 promising early- to late-stage medical device companies seeking funding and/or strategic partnership are already confirmed to present at its 'Investment In Innovation (In3) West' conference, being held February 27-29, 2008 in Las Vegas.
Octillion Corp. today announced expansion of the Company's research and development program with plans to identify, evaluate and acquire strategic enabling and complementary photovoltaic technologies in order to further accelerate development of the world's first-of-its-kind transparent window capable of generating electricity.
AIXTRON AG announced the installation and commissioning of a Nanoinstruments Black Magic 2-inch R&D equipment for carbon nanotube growth at the Physics and Chemistry Research Facility, University of Tuebingen, Germany.
Asylum Research, a premier manufacturer of atomic force microscopes, announced that the federal court in Los Angeles dismissed two of the five Veeco Instruments Inc. patents from the infringement lawsuit commenced by Veeco in September 2003 and that the judge's summary judgment order cast a large shadow over their remaining patents.
CVD Equipment Corporation announced today that Gary Dyal, Director of Marketing and Sales will present at the 3rd Annual Axiom Capital/Livingston Nanotechnology Conference at the Marriott Financial Center in New York City on December 7th, 2007.